Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Houssami N, Turner R, Morrow M (2017) Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat 165(2):273–283CrossRefPubMedPubMedCentral
2.
Arnaout A, Catley C, Booth C, McInnes M, Graham I, Kumar V, Simos D, Van Walraven C, Clemons M (2015) Use of preoperative magnetic resonance imaging for breast cancer: A Canadian population-based study. JAMA Oncol 1(9):1238–1250CrossRefPubMed
3.
Peters N, van Esser S, van den Bosch M, Storm R, Plaisier P, van Dalen T, Diepstraten S, Weits T, Westenend P, Stapper G et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 47(6):879–886CrossRefPubMed
Metadata
Title
Association between pre-operative magnetic resonance imaging (MRI) and surgical outcomes in breast cancer: not yet determined
Authors
Ran Xu
Peipei Tang
Chunmei Li
Publication date
01-02-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-5010-9

Other articles of this Issue 3/2019

Breast Cancer Research and Treatment 3/2019 Go to the issue

Epidemiology

Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society

Review

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

Preclinical study

Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer

Review

Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer

Brief Report

Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy

Epidemiology

The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits